Cat. No. |
Product Name |
Information |
PC-61534 |
V116517
TRPV1 inhibitor
|
V116517 is a potent, selective, oral bioavailable TRPV1 antagonist with IC50 of 35.1 nM. |
PC-61533 |
ABT-102
TRPV1 antagonist
|
ABT-102 is a potent, highly selective, orally active TRPV1 antagonist that inhibits agonist-evoked increases in intracellular Ca(2+) levels with IC50 of 5-7 nM. |
PC-61374 |
Elismetrep
TRPM8 antagonist
|
Elismetrep (MT-8554) is a novel specific TRPM8 channel antagonist for treatment or prevention vasomotor symptoms. |
PC-70337 |
GSK 2833503A
TRPC3/6 inhibitor
|
GSK 2833503A (GSK2833503A, GSK503A) is a potent, and selective inhibitor of TRPC3/6 channels with IC50 of 4 nM/5 nM, respectively. |
PC-70336 |
GSK 2332255B
TRPC3/6 inhibitor
|
GSK 2332255B (GSK2332255B, GSK255B) is a potent, and selective inhibitor of TRPC3/6 channels with IC50 of 3 nM/21 nM, respectively. |
PC-61156 |
ASP7663
TRPA1 agonist
|
ASP7663 is a potent, selective, orally active TRPA1 receptor agonist with EC50 of 0.51, 0.54 and 0.50 uM for human, rat and mouse TRPA1, respectively. |
PC-61124 |
AM-0902
TRPA1 inhibitor
|
AM-0902 (AMG0902) is a potent, selective, orally active TRPA1 channel antagonist with IC50 of 71 and 131 nM for rTRPA1 and hTRPA1 in Ca2+ flux assays respectively, without agonist activity (EC50>40 uM). |
PC-60846 |
Pico145
TRPC1/4/5 inhibitor
|
Pico145 is a highly potent, subtype-selective TRPC1/4/5 channels inhibitor with potency ranged from 9 to 1300 pM, depending on the TRPC1/4/5 subtype and activation mechanism. |
PC-60788 |
(S)-PBMC
TRPM8 antagonist
|
(S)-PBMC is a potent, selective TRPM8 antagonist with IC50 of 15.6 nM (hTRPM8). |
PC-60787 |
RQ-00203078
|
A potent, selective and orally available TRPM8 channel inhibitor with IC50 of 8.3 nM (hTRPM8). |
PC-60786 |
WS-12
TRPM8 agonist
|
WS-12 (Acoltremon, AR-15512, AVX-012) is a potent, selective TRPM8 agonist with EC50 of 12 uM, a cooling agent. |
PC-60785 |
PF-05105679
TRPM8 antagonist
|
PF-05105679 is a potent, selective TRPM8 channel inhibitor with IC50 of 103 nM (human TRPM8 currents inhibition). |